First in Human Study in Healthy Volunteers to Investigate the Safety, Tolerability and Pharmacokinetics of BAY1214784

NCT02212080 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Clinical Trials, Phase I as Topic

Interventions

DRUG: BAY1214784
DRUG: Placebo

Sponsor

Bayer